Chi Wei Cliburn Chan

Title: Innovating Immune Monitoring: The Contributions of Chi Wei Cliburn Chan

Introduction: Chi Wei Cliburn Chan is a notable inventor based in Durham, North Carolina, recognized for his significant contribution to the field of medical innovation. With one patented invention, Chan is at the forefront of developing methods to enhance patient care following transplantation or immunosuppression.

Latest Patents: Chan's patent titled "Immune monitoring to predict and prevent infection" focuses on innovative methods for evaluating the risk of infection in subjects after undergoing transplantation or immunosuppression. The patent outlines techniques for determining when a subject should receive prophylactic treatment with anti-microbial agents. Additionally, it includes specific kits designed to facilitate the implementation of these methods, thereby improving patient outcomes through proactive infection management.

Career Highlights: Currently, Chi Wei Cliburn Chan is affiliated with Duke University, where he applies his expertise in research and development. His work primarily revolves around immune monitoring and infection prevention, contributing to advancements that support immunocompromised patients.

Collaborations: In his pursuit of innovation, Chan collaborates with esteemed colleagues, including Scott M. Palmer and Kent J. Weinhold. Together, they work on enhancing methodologies and exploring new avenues in immune monitoring and infection prevention, enriching the field through teamwork and shared expertise.

Conclusion: Chi Wei Cliburn Chan exemplifies the role of an inventor dedicated to advancing medical practices and improving patient care. His patent on immune monitoring not only showcases his innovative thinking but also highlights the importance of collaboration in research advancements at institutions like Duke University. Through his efforts, the landscape of infection prevention in medical contexts continues to evolve and improve.